Drug to treat severe Crohn’s disease could ease pain for hundreds of patients
A DRUG which can treat people living with moderate to severely active Crohn’s disease has been approved for use for people in the UK – news which could reduce crippling symptoms and suffering many people face.Following European Commission approval, the drug ustekinumab or Stelara is now licensed in the UK as a treatment option for adult patients who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy.Ustekinumab is the first biologic drug for Crohn’S Disease Treatment two, specific, naturally-occurring proteins which play a key role in inflammatory and immune responses.
Miracle Drug For Crohn’S Disease Treatment Could Ease Pain of Million Patients:The biologics are designed to target and obstruct specific components of the immune system.At least 115,000 people in the UK have Crohn’s disease and around one in 10,000 people are newly diagnosed every year.Crohn’s disease is a chronic inflammatory bowel disease which can affect anyone of any age or gender, although it predominantly impacts people in the prime of their lives between the ages of 16 to 30.
As a life-long condition, a diagnosis of Crohn’s disease can severely impact on a person’s ability to engage fully in day-to-day life, such as work or social situations, due to a range of debilitating symptoms associated with the disease, including abdominal pain and cramping, frequent diarrhoea, depression, anaemia and even colorectal cancer.Sarah Berry, Crohn’S Disease and Colitis UK said: “The impact of uncontrollable symptoms of Crohn’s Disease on a person’s life can be debilitating and devastating.“We therefore welcome the addition of any new treatment option which could have a positive impact on the quality of life for those in this position and their families.
Miracle Drug For Crohn’S Disease Treatment:”Some experts warn there is currently a significant unmet medical need in Crohn’s disease, with less than half of patients maintaining relief from their symptoms for more than one year with currently available therapies.While some patients experience Crohn’s disease as a constant disease, the majority of patients experience an unpredictable cycle of flare-ups with periods of less active remission, which can have a negative impact on a patient’s quality of life and emotional well-being.
Miracle Drug For Crohn’S Disease Treatment Could Ease Pain of Million Patients:This can be further exacerbated by fear of stigma and isolation, which adds to the emotional burden experienced by patients.Surgery may become necessary when treatment and dietary changes no longer control symptoms or as other complications arise.Hospitalisation rates are high in patients with Crohn’s disease, with 60 per cent of patients undergoing surgical treatment within 10 years and 45 per cent of patients requiring more than one operation.Breakthrough treatment could save Drug For Crohn’S Disease Treatment Could Ease Pain of Million Patients sufferers from diarrhoea and severe pain. Source